Quick Takeaways
- CVI Investments, Inc. filed SCHEDULE 13G for BriaCell Therapeutics Corp. Common Shares, no par value (BCTX).
- Disclosed ownership: 5.7%.
- Date of event: 15 Jul 2025.
CVI Investments, Inc. - 15 Jul 2025 SCHEDULE 13G Report for BriaCell Therapeutics Corp. Common Shares, no par value (BCTX)
- Filing Manager
- CVI Investments, Inc.
- Reporting Manager
- CVI Investments, Inc.
- Symbol
- BCTX
- Shares outstanding
- 17,543,860 shares
- Disclosed Ownership
- 1,000,000 shares
- Ownership
- 5.7%
- Form type
- SCHEDULE 13G
- Filing time
- 22 Jul 2025, 09:59:10 UTC
- Date of event
- 15 Jul 2025
- Previous filing
- 21 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"CVI Investments, Inc. disclosed 5.7% ownership in BriaCell Therapeutics Corp. Common Shares, no par value (BCTX) on 15 Jul 2025."
What Changed
- Previous schedule filing date: 21 Jul 2025.
- Current filing was accepted on 22 Jul 2025, 09:59.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 5.7% | 1,000,000 | 0 | 1,000,000 | /s/ Sarah Travis | Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc. | |
| Heights Capital Management, Inc. | 5.7% | 1,000,000 | 0 | 1,000,000 | /s/ Sarah Travis | Sarah Travis, Assistant General Counsel and Assistant Secretary |